HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 1 filers reported holding HORIZON THERAPEUTICS PUB L in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $210 | -40.0% | 1,816 | -46.6% | 0.00% | 0.0% |
| Q2 2023 | $350 | -49.0% | 3,401 | -45.9% | 0.00% | -66.7% |
| Q1 2023 | $686 | -8.4% | 6,288 | -4.5% | 0.00% | 0.0% |
| Q4 2022 | $749 | -99.7% | 6,581 | +47.0% | 0.00% | +200.0% |
| Q3 2022 | $277,000 | -53.2% | 4,478 | -39.1% | 0.00% | -66.7% |
| Q2 2022 | $592,000 | -22.7% | 7,348 | +0.9% | 0.00% | 0.0% |
| Q1 2022 | $766,000 | +59.9% | 7,284 | +63.7% | 0.00% | +50.0% |
| Q4 2021 | $479,000 | +62.9% | 4,449 | +65.8% | 0.00% | +100.0% |
| Q3 2021 | $294,000 | -25.2% | 2,684 | -36.1% | 0.00% | -50.0% |
| Q2 2021 | $393,000 | -0.5% | 4,198 | -2.1% | 0.00% | 0.0% |
| Q1 2021 | $395,000 | +82.9% | 4,288 | +10.4% | 0.00% | +100.0% |
| Q2 2020 | $216,000 | – | 3,885 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 548,715 | $59,130,000 | 25.86% |
| Paulson & Co. | 6,000,000 | $646,560,000 | 19.94% |
| Avoro Capital Advisors LLC | 9,295,000 | $1,001,629,000 | 17.05% |
| Asymmetry Capital Management, L.P. | 137,610 | $14,829,000 | 7.87% |
| 1492 Capital Management LLC | 119,995 | $12,931,000 | 6.37% |
| Eversept Partners, LP | 833,750 | $89,844,900 | 5.74% |
| HealthCor Management, L.P. | 832,270 | $89,685,000 | 4.88% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 1,063,236 | $114,574,000 | 4.38% |
| PFM Health Sciences, LP | 1,091,840 | $117,657,000 | 4.01% |
| Ikarian Capital, LLC | 246,900 | $26,607,000 | 3.96% |